Reversal of multidrug resistance in renal cell carcinoma by short hairpin RNA targeting MDR1 gene

Chinese Medical Journal

Volumn 125, Issue 15, 2012, Pages 2741-2745

  Hao, Yi Xin ^a   He, Zheng Wen ^b   Zhu, Jian Hua ^a   Shen, Qian ^b   Sun, Jun Zhong ^a   Du, Nan ^a   Xiao, Wen Hua ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Multidrug resistance; P glycoprotein; Renal cell carcinoma; Short hairpin RNA

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GLYCOPROTEIN P; LENTIVIRUS VECTOR; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; SHORT HAIRPIN RNA; VINCRISTINE;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; KIDNEY CARCINOMA; MDR1 GENE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INHIBITORY CONCENTRATION 50; LENTIVIRUS; P-GLYCOPROTEIN; RNA, SMALL INTERFERING;

EID: 84865643894     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.15.016     Document Type: Article

References (22)

1. Vogelzang NJ, Stadler WM. Kidney cancer. Lancet 1998; 352: 1691-1696.
2. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol 2000; 163: 408-417.
3. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug- resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A 1987; 84: 265-269.
4. Baird RD, Kaye SB. Drug resistance reversal -- are we getting closer? Eur J Cancer 2003; 39: 2450-2461.
5. Wu L, Smythe AM, Stinson SF, Mullendore LA, Monks A, Scudiero DA, et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 1992; 52: 3029-3034.
6. Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, et al. Generation of a drug resistance profile by quantitation of MDR-1/P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J Clin Invest 1995; 95: 2205-2214.
7. Mickisch GH, Kössig J, Keilhauer G, Schlick E, Tschada RK, Alken PM. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res 1990; 50: 3670-3674.
8. Mickisch GH, Roehrich K, Koessig J, Forster S, Tschada RK, Alken PM. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol 1990; 144: 755-759.
9. Lehnert M. Multidrug resistance in human cancer. J Neurooncol 1994; 22: 239-243.
10. Naito S, Sakamoto N, Kotoh S, Goto K, Matsumoto T, Kumazawa J. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma. Eur Uro 1993; l24: 156-160.
11. Rochlitz CF, Lobeck H, Peter S, Reuter J, Mohr B, de Kant E, et al. Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype. Cancer 1992; 69: 2993-2998.
12. Kanamaru H, Kakehi Y, Yoshida O, Nakanishi S, Pastan I, Gottesman MM. MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 1989; 81: 844-849.
13. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58.
14. Hannon GJ. RNA interference. Nature 2002; 418: 244-251.
15. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15: 188-200.
16. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
17. An DS, Xie Y, Mao SH, Morizono K, Kung SK, Chen IS. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther 2003; 14: 1207-1212.
18. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003; 63: 1515-1519.
19. Nieth C, Priebsch A, Stege A, Lage H. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003; 545: 144-150.
20. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33: 401-406.
21. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003; 9: 493-501.
22. Abbas-Terki T, Blanco-Bose W, Deglon N, Pralong W, Aebischer P. Lentiviral-mediated RNA interference. Hum Gene Ther 2002; 13: 2197-2201.